NORML worked with union members for nearly two years to assist them in securing the revisions.
Category: Medical Cannabis
“These results affirm the longstanding experiences of patients, many of whom either reduce or eliminate their use of opioids after initiating cannabis therapy because they perceive cannabis to be a safer and more effective alternative.”
The passage of the new rules mark the latest effort by regulators to undermine the state’s 2024 voter-approved medical cannabis access law, which Nebraskans supported by a margin of more than 2 to 1.
“Nearly one-third of migraine sufferers have tried cannabis for symptom management, and patients consistently report that it significantly reduces their pain severity and migraine frequency. These data further affirm patients’ testimonials.”
“Initiation of THC-dominant medicinal cannabis was associated with acute reductions in anxiety and depression, and sustained reductions in overall symptom severity over a 6-month period,” researchers reported.
The new law opens the Texas Compassionate Use Program to include those suffering from chronic pain and other newly eligible conditions. It also expands the variety of cannabis formulations that patients possess and significantly increases the total number of state-licensed dispensaries that can operate in the state.
“Recreational cannabis laws result in significant relative declines in prescription drug claims. … The legalization of cannabis offers a potential substitute to traditional prescription drugs and alternative methods for health maintenance.”
“These numbers show meaningful changes in disturbed sleep and fatigue for patients after starting medical cannabis.”